Trial · NCT02052310
Adverse events834
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 834
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhea | Gastrointestinal disorders | Roxadustat | 72 | 522 | |
| other | Diarrhea | Gastrointestinal disorders | Epoetin Alfa | 38 | 517 | |
| other | Nausea | Gastrointestinal disorders | Roxadustat | 45 | 522 | |
| other | Nausea | Gastrointestinal disorders | Epoetin Alfa | 30 | 517 | |
| other | Constipation | Gastrointestinal disorders | Roxadustat | 35 | 522 | |
| other | Constipation | Gastrointestinal disorders | Epoetin Alfa | 23 | 517 | |
| other | Vomiting | Gastrointestinal disorders | Roxadustat | 32 | 522 | |
| other | Vomiting | Gastrointestinal disorders | Epoetin Alfa | 17 | 517 | |
| other | Arteriovenous fistula thrombosis | Injury, poisoning and procedural complications | Roxadustat | 26 | 522 | |
| other | Arteriovenous fistula thrombosis | Injury, poisoning and procedural complications | Epoetin Alfa | 28 | 517 | |
| other | Arteriovenous fistula site complication | Injury, poisoning and procedural complications | Roxadustat | 27 | 522 | |
| other | Arteriovenous fistula site complication | Injury, poisoning and procedural complications | Epoetin Alfa | 42 | 517 | |
| other | Procedural hypotension | Injury, poisoning and procedural complications | Roxadustat | 25 | 522 | |
| other | Procedural hypotension | Injury, poisoning and procedural complications | Epoetin Alfa | 31 | 517 | |
| other | Hyperphosphatemia | Metabolism and nutrition disorders | Roxadustat | 52 | 522 | |
| other | Hyperphosphatemia | Metabolism and nutrition disorders | Epoetin Alfa | 35 | 517 | |
| other | Hyperkalemia | Metabolism and nutrition disorders | Roxadustat | 24 | 522 | |
| other | Hyperkalemia | Metabolism and nutrition disorders | Epoetin Alfa | 30 | 517 | |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | Roxadustat | 60 | 522 | |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | Epoetin Alfa | 39 | 517 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02052310/events